BioRem Inc. (CVE:BRM – Free Report) – Equities research analysts at Cormark lowered their FY2026 EPS estimates for BioRem in a research report issued to clients and investors on Tuesday, August 26th. Cormark analyst N. Boychuk now expects that the company wil…